SynAct Pharma AB (SYNACT) — Net Asset Quality Index
SynAct Pharma AB (SYNACT) has a Net Asset Quality Index of 81.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr237.88 Million minus total liabilities of Skr44.13 Million yields net assets of Skr193.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. See SYNACT defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
SynAct Pharma AB Net Asset Quality Index Over Time (2014–2025)
This chart shows how SynAct Pharma AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at 81.4%, representing net assets of Skr193.75 Million against total assets of Skr237.88 Million SEK. Explore SynAct Pharma AB operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for SynAct Pharma AB (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for SynAct Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see SYNACT market cap overview.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.2% | Skr170.29 Million | Skr220.52 Million | Skr50.23 Million | ▼ -1.9 pp |
| 2024 | 79.2% | Skr214.17 Million | Skr270.52 Million | Skr56.35 Million | ▲ +1.9 pp |
| 2023 | 77.3% | Skr176.19 Million | Skr228.02 Million | Skr51.83 Million | ▼ -11.5 pp |
| 2022 | 88.7% | Skr126.52 Million | Skr142.60 Million | Skr16.08 Million | ▲ +34.3 pp |
| 2021 | 54.4% | Skr20.87 Million | Skr38.37 Million | Skr17.50 Million | ▼ -19.1 pp |
| 2020 | 73.5% | Skr15.87 Million | Skr21.59 Million | Skr5.72 Million | ▲ +16.8 pp |
| 2019 | 56.7% | Skr13.50 Million | Skr23.81 Million | Skr10.31 Million | ▼ -16.8 pp |
| 2018 | 73.5% | Skr10.31 Million | Skr14.03 Million | Skr3.72 Million | ▼ -11.3 pp |
| 2017 | 84.8% | Skr12.91 Million | Skr15.23 Million | Skr2.31 Million | ▼ -3.8 pp |
| 2016 | 88.6% | Skr27.08 Million | Skr30.57 Million | Skr3.49 Million | ▲ +3.7 pp |
| 2015 | 84.9% | Skr320.00K | Skr377.00K | Skr57.00K | ▼ -3.9 pp |
| 2014 | 88.8% | Skr642.00K | Skr723.00K | Skr81.00K | — |